Authors: Nathanson, S Fremeaux-Bacchi, V Deschenes, G

Citation: S. Nathanson et al., Successful plasma therapy in hemolytic uremic syndrome with factor H deficiency, PED NEPHROL, 16(7), 2001, pp. 554-556

Authors: Dragon-Durey, MA Quartier, P Fremeaux-Bacchi, V Blouin, J de Barace, C Prieur, AM Weiss, L Fridman, WH

Citation: Ma. Dragon-durey et al., Molecular basis of a selective C1s deficiency associated with early onset multiple autoimmune diseases, J IMMUNOL, 166(12), 2001, pp. 7612-7616

Authors: Cacoub, P Fremeaux-Bacchi, V De Lacroix, I Guillien, F Kahn, MF Kazatchkine, MD Godeau, P Piette, JC

Citation: P. Cacoub et al., A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus, ARTH RHEUM, 44(8), 2001, pp. 1836-1840

Authors: Fischer, EM Mouhoub, A Maillet, F Fremeaux-Bacchi, V Krief, C Gould, H Berrih-Aknin, S Kazatchkine, MD

Citation: Em. Fischer et al., Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes, INT IMMUNOL, 11(11), 1999, pp. 1841-1849

Authors: Fremeaux-Bacchi, V Kolb, JP Rakotobe, S Kazatchkine, MD Fischer, EM

Citation: V. Fremeaux-bacchi et al., Functional properties of soluble CD21, IMMUNOPHARM, 42(1-3), 1999, pp. 31-37

Authors: Fremeaux-Bacchi, V Aubry, JP Bonnefoy, JY Kazatchkine, MD Kolb, JP Fischer, EM

Citation: V. Fremeaux-bacchi et al., Soluble CD21 induces activation and differentiation of human monocytes through binding to membrane CD23, EUR J IMMUN, 28(12), 1998, pp. 4268-4274